[Hormone replacement therapy and urogenital disease in postmenopausal women].
Estrogen deficit in postmenopausal women causes urogenital atrophy, which is responsible for a wide range of urinary disorders (urinary incontinence, urge incontinence, recurrent urinary infections) and genital disorders (prolapse, dispareunya, vaginal dryness). The efficacy of estrogen therapy on urinary incontinence is not yet demonstrated, but it is widely recognized that the topical use of estrogens lowers the risk of recurrent urinary infections and improves urogenital atrophy.
Clinica di Ostetricia e Ginecologia, Azienda Ospedaliero Universitaria di Udine Udine, Italia. m.dellamartina@libero.it
M
M
Della Martina
S
S
Xodo
E
E
Vogrig
D
D
Rinuncini
L
L
Ganzitti
L
L
Driul
G
G
Fabiani
D
D
Marchesoni
D005260:Female; D052776:Female Urogenital Diseases / Q000188:drug therapy*; D020249:Hormone Replacement Therapy; D006801:Humans; D017698:Postmenopause; D012008:Recurrence; D014549:Urinary Incontinence / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy